참고문헌
- Vokes EE, Weichselbaum RR, Lippman SM, Hong WK : Head and Neck Cancer. N Engl J Med. 1993 ; 328 : 184-194 https://doi.org/10.1056/NEJM199301213280306
- Clayman GL, Liu TJ, Overholt M : Gene therapy for head and neck cancer : comparing the tumor suppressor gene p53 and a cell cycle regulator WAF1/CIP1 (p21). Arch Otolaryngol Head Neck Sur. 1996 ; 122 : 489-493 https://doi.org/10.1001/archotol.1996.01890170025006
- O'Malley BW, Cope KJ, Chen SH, Li D, Schwartz R, Woo SL : Combination gene therapy for oral cancer in a murine model. Cancer Res. 1996 ; 56 : 1737-1741
- Myers JN, Mank-Seymour A, Zitvogel L, et al : Interleukin-12 gene therapy prevents establishment of SCCVII squamous cell carcinomas, Inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice. Laryngoscope. 1998 ; 108 : 261-268 https://doi.org/10.1097/00005537-199802000-00019
- Golumbek PT, Lazenby AJ, Levitsky HI : Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science. 1991 ; 254 : 713-716 https://doi.org/10.1126/science.1948050
- Saito S, Bannerji R, Gansbacher B, et al : Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res. 1994 ; 54 : 3516-3250
- Dranoff G, Jaffee E, Lazenby A : Vaccination with irradiated tumor cells engineered to secret murine granulocyte-macrophage colony-stimulating factor stimulate potent, specific, and longlasting anti-tumor immunity. Proc Natl Acad Sci USA. 1993 ; 90 : 3539-3543 https://doi.org/10.1073/pnas.90.8.3539
- Rosenberg SA, Anderson WE Blaese MR, Etting-hausen SE, Hwu P, Karp SE : Initial proposal ofclinical research project : Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for interleukin-Z. Hum Gene Ther. 1992 ; 3 : 75-90 https://doi.org/10.1089/hum.1992.3.1-75
- Geller AI, Keyomarsi K, Bryan J, Pardee AB : An efficient deletion mutation packaging system for defective herpes simplex virus vectors. Potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci USA. 1990 ; 87 : 8950-8954 https://doi.org/10.1073/pnas.87.22.8950
- Tung C, Federoff HJ, Brownlee M, et al : Rapid production of interleukine-2-secreting tumor cells by herpes simplex virusmediated gene transfer : Implications for autologous vaccine production. Hum Gene Ther. 1996 ; 7 : 2217-2224 https://doi.org/10.1089/hum.1996.7.18-2217
- Karpoff HM, Angelica MD, Blair S, Browulee MD, Federoff H, Fong Y : Prevention of hepatic tumor metastases in rats with herpes viral vaccinations and r-interferon. J Clin Invest. 1997 ; 99 : 799-804 https://doi.org/10.1172/JCI119226
- Mclean CS, Erturk M, Jennings R, et al : Protective vaccination against primary and reccurent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. JID. 1994 ; 170 : 1100-1109 https://doi.org/10.1093/infdis/170.5.1100
- Kim SH, Carew JF, Kooby DA, et al : Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer. Cancer Gene Ther. 2000 ; 7 (9) : 1279-1285 https://doi.org/10.1038/sj.cgt.7700231
- Boursnell MEG, Entwisle C, Blakeley D, Roberts C, Duncan IA, McLean CS : A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provide effective protection against primary and recurrent HSV-2 disease. J Infec Dis. 1997 ; 175 : 16-25 https://doi.org/10.1093/infdis/175.1.16
- Geller AI, Breakfield XO : A defective HSV-1 vector expresses Escherichia coli B-galactosidase in cultured peripheral neurons. Science. 1988 ; 241 : 1667-1669 https://doi.org/10.1126/science.2843986
- Anderson WF : Human gene therapy. Science. 1992 May 8 : 256 (5058) : 808-813
- Prehn RT, Main JM : Immunity to methylcholanthrene induced sarcomas. J Natl Cancer Inst. 1957 : 18 : 767-778
- Blankenstein T : Increasing tumor immunogenicity by genetic modification. Eur J Cancer. 1994 : 30 : 1182-1187 https://doi.org/10.1016/0959-8049(94)90480-4
- Scott AM, Cebon J : Clinical promise of tumor immunology. Lancet. 1997 : 349 (suppl II) : 19-22
- Gilboa E : Immunotherapy of cancer with modified tumor vaccines. Semin Oncol. 1996 : 23 : 101-107
- Dranoff G, Mulligan RC : Gene transfer as cancer therapy. Adv Immunol. 1995 : 58 : 417-454 https://doi.org/10.1016/S0065-2776(08)60624-0
- Carew JF, Federoff H, Halterman M, et al : Efficient gene transfer to humn squamous cell carcinoma by the herpes simplex virus typel amplicon vector. Am J Surg. 1998 : 176 : 404-408
- Fong Y, Federoff HJ, Brownlee M, Blumberg D, Blumgart LH, Brennan M : Rapid and efficient gene transfer in human hepatocytes by herpes viral vectors. Hepatology. 1995 : 22 : 723-729
- Tung C, Federoff HJ, Brownlee M, et al : Rapid production of interleukine-2-secreting tumor cells by herpes simplex virus-mediated gene transfer : Implications for autologous vaccine production. Hum Gene Ther. 1996 : 7 : 2217-2224